These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17293388)

  • 1. Vancomycin administration: the impact of multidisciplinary interventions.
    Crowley RK; Fitzpatrick F; Solanki D; FitzGerald S; Humphreys H; Smyth EG
    J Clin Pathol; 2007 Oct; 60(10):1155-9. PubMed ID: 17293388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
    Truong J; Levkovich BJ; Padiglione AA
    Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriateness of vancomycin therapeutic drug monitoring and its outcomes among non-dialysis patients in a tertiary hospital in Singapore.
    Seng JJB; Yong MHA; Peh ZX; Soong JL; Tan MH
    Int J Clin Pharm; 2018 Oct; 40(5):977-981. PubMed ID: 29948742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a pharmacist-to-dose computerized request on promptness of antimicrobial therapy.
    Vincent WR; Martin CA; Winstead PS; Smith KM; Gatz J; Lewis DA
    J Am Med Inform Assoc; 2009; 16(1):47-53. PubMed ID: 18952947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitfalls in TDM of antibiotic drugs: analytical and modelling issues.
    Neef C; Touw DJ; Harteveld AR; Eerland JJ; Uges DR
    Ther Drug Monit; 2006 Oct; 28(5):686-9. PubMed ID: 17038886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring.
    Swartling M; Gupta R; Dudas V; Guglielmo BJ
    Int J Clin Pharm; 2012 Apr; 34(2):282-5. PubMed ID: 22331444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [TDM management system for contribution to proper use of anti-mRSA drugs--establishment of cooperation support system between pharmacy and clinical laboratory in hospital].
    Yodoshi M; Iwasaki N; Satoh K; Nomura M; Morishima Y; Nakae K; Yamazoe Y
    Rinsho Byori; 2013 Feb; 61(2):127-34. PubMed ID: 23672090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies.
    Fernández de Gatta MD; Calvo MV; Hernández JM; Caballero D; San Miguel JF; Domínguez-Gil A
    Clin Pharmacol Ther; 1996 Sep; 60(3):332-40. PubMed ID: 8841156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications and impact of prior authorization policy on vancomycin use at a tertiary pediatric teaching hospital.
    Chan S; Hossain J; Di Pentima MC
    Pediatr Infect Dis J; 2015 May; 34(5):506-8. PubMed ID: 25379832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug use density in critically ill children and newborns: analysis of various methodologies.
    Valcourt K; Norozian F; Lee H; Raszynski A; Torbati D; Totapally BR
    Pediatr Crit Care Med; 2009 Jul; 10(4):495-9. PubMed ID: 19451853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An audit of therapeutic drug monitoring of anticonvulsants.
    Sharpe PC; Morrow J; Trimble ER
    Ulster Med J; 1995 Oct; 64(2):151-6. PubMed ID: 8533181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of vancomycin therapeutic drug monitoring on patient care.
    Welty TE; Copa AK
    Ann Pharmacother; 1994 Dec; 28(12):1335-9. PubMed ID: 7696720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units.
    Kadambari S; Heath PT; Sharland M; Lewis S; Nichols A; Turner MA
    J Antimicrob Chemother; 2011 Nov; 66(11):2647-50. PubMed ID: 21862473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacist interventions to improve prescribing of vancomycin and tobramycin.
    Fletcher CV; Giese RM; Rodman JH
    Am J Hosp Pharm; 1986 Sep; 43(9):2198-201. PubMed ID: 3766572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention study.
    Li J; Udy AA; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2012 Jan; 39(1):69-72. PubMed ID: 22024354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective vancomycin audit in Auckland healthcare hospitals.
    Drinkovic D; Taylor SL; Pottumarthy S; Morris AJ
    N Z Med J; 1999 Sep; 112(1095):336-9. PubMed ID: 10553935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing the Time of Blood Collection to Determine Vancomycin Concentrations in Intensive Care Unit Patients.
    Hammond DA; James TB; Atkinson LN; Painter JT; Lusardi K
    Crit Care Nurse; 2018 Feb; 38(1):24-28. PubMed ID: 29437075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
    Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
    Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.